Medicare Enrolled

Dr. Juan Sanchez, MD

Optician · Cerritos, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
18000 STUDEBAKER RD STE 800, Cerritos, CA 90703
5627353226
In practice since 2006 (19 years)
NPI: 1447298633 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sanchez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sanchez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sanchez

Dr. Juan Sanchez is an optician specialist in Cerritos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sanchez performed 185 Medicare services across 90 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sanchez received a total of $13,099 from 73 pharmaceutical and/or device companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sanchez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 185 Medicare services $13,099 industry payments

Medicare Practice Summary

Medicare Utilization ↗
185
Medicare services
Bottom 17% in CA for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
90
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
130 $104 $255
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $77 $187
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
20 $66 $182
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $142 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,099
Total received (2019-2024)
Avg $2,183/year across 6 years
Top 11% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
559
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,230 (93.4%)
Other
Charitable contributions, space rental, and other categories
$591 (4.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$278 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,878
2023
$2,577
2022
$2,157
2021
$2,161
2020
$915
2019
$2,411

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$343
Janssen Biotech, Inc.
$248
AstraZeneca Pharmaceuticals LP
$212
PFIZER INC.
$165
Incyte Corporation
$140
Daiichi Sankyo Inc.
$140
Eisai Inc.
$123
ABBVIE INC.
$123
Astellas Pharma US Inc
$122
EMD Serono, Inc.
$113
Lilly USA, LLC
$102
E.R. Squibb & Sons, L.L.C.
$93
Regeneron Healthcare Solutions, Inc.
$92
Ipsen Biopharmaceuticals, Inc
$82
Genmab U.S., Inc.
$65
Exelixis Inc.
$62
Celgene Corporation
$54
ARRAY BIOPHARMA INC
$49
Agios Pharmaceuticals, Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$44
Tempus AI, Inc
$42
TerSera Therapeutics LLC
$36
Alexion Pharmaceuticals, Inc.
$34
Stemline Therapeutics Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$29
PharmaEssentia USA Corporation
$28
Karyopharm Therapeutics Inc.
$26
SOBI, INC
$24
SpringWorks Therapeutics, Inc.
$24
Merck Sharp & Dohme LLC
$24
PUMA BIOTECHNOLOGY, INC.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Rigel Pharmaceuticals, Inc.
$21
TAIHO ONCOLOGY, INC.
$20
GlaxoSmithKline, LLC.
$20
Genentech USA, Inc.
$18
Mirati Therapeutics, Inc.
$18
BeiGene USA, Inc.
$16
Top 3 companies account for 27.9% of 2024 payments
All-time payments by company (2019-2024) ›
Novartis Pharmaceuticals Corporation
$1,060
Incyte Corporation
$713
PFIZER INC.
$641
AstraZeneca Pharmaceuticals LP
$637
Takeda Pharmaceuticals U.S.A., Inc.
$635
Lilly USA, LLC
$625
E.R. Squibb & Sons, L.L.C.
$592
Janssen Biotech, Inc.
$524
Celgene Corporation
$469
GENZYME CORPORATION
$434
Eisai Inc.
$388
GlaxoSmithKline, LLC.
$371
Astellas Pharma US Inc
$347
Karyopharm Therapeutics Inc.
$340
Merck Sharp & Dohme Corporation
$301
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Seagen Inc.
$245
Amgen Inc.
$216
Exelixis Inc.
$216
EMD Serono, Inc.
$213
Daiichi Sankyo Inc.
$211
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
Bayer HealthCare Pharmaceuticals Inc.
$159
Ipsen Biopharmaceuticals, Inc
$151
Rigel Pharmaceuticals, Inc.
$149
Genentech USA, Inc.
$148
Regeneron Healthcare Solutions, Inc.
$146
BeiGene USA, Inc.
$144
EISAI INC.
$128
ABBVIE INC.
$123
ARRAY BIOPHARMA INC
$122
Genmab U.S., Inc.
$121
Pharmacyclics LLC, An AbbVie Company
$115
Blueprint Medicines Corporation
$111
Alexion Pharmaceuticals, Inc.
$106
Kite Pharma, Inc.
$104
TOLMAR Pharmaceuticals, Inc.
$101
TerSera Therapeutics LLC
$90
Bayer Healthcare Pharmaceuticals Inc.
$89
Stemline Therapeutics Inc.
$83
Pharmacyclics LLC, an AbbVie Company
$82
Blue Earth Diagnostics Limited
$76
PharmaEssentia USA Corporation
$72
Merck Sharp & Dohme LLC
$71
TESARO, Inc.
$68
TAIHO ONCOLOGY, INC.
$62
Teva Pharmaceuticals USA, Inc.
$59
Clovis Oncology, Inc.
$54
Sun Pharmaceutical Industries Inc.
$52
Agios Pharmaceuticals, Inc.
$47
MorphoSys, US Inc.
$47
Tempus AI, Inc
$42
Seattle Genetics, Inc.
$42
PUMA BIOTECHNOLOGY, INC.
$41
GE HealthCare
$36
AbbVie, Inc.
$36
Janssen Scientific Affairs, LLC
$29
Gilead Sciences, Inc.
$28
Puma Biotechnology, Inc.
$28
SOBI, INC
$24
SpringWorks Therapeutics, Inc.
$24
AMAG Pharmaceuticals, Inc.
$24
Mylan Institutional Inc.
$23
JAZZ PHARMACEUTICALS INC.
$23
Helsinn Therapeutics (U.S.), Inc.
$23
Dendreon Pharmaceuticals LLC
$22
Taiho Oncology, Inc.
$22
Tolmar, Inc.
$22
Alnylam Pharmaceuticals Inc.
$21
Dova Pharmaceuticals
$18
Mirati Therapeutics, Inc.
$18
Epizyme, Inc.,
$17
Acceleron Pharma, Inc.
$17
Top 3 companies account for 18.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Alecensa · Axumin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · FERAHEME · Fabhalta · GAUCHER-DISEASE · GAVRETO · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Idhifa · Inrebic · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pomalyst · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tazverik · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Vyloy · XALKORI · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Cerritos?
Compare opticians in the Cerritos area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,639
Per 100K population
16.6
County median income
$87,760
Nearest hospital
COLLEGE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sanchez is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sanchez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sanchez performed 130 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sanchez receive payments from pharmaceutical companies?
Yes. Dr. Sanchez received a total of $13,099 from 73 companies across 559 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sanchez's costs compare to other opticians in Cerritos?
Dr. Sanchez's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sanchez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →